Zulu
English French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur
Leave Your Message
Imikhiqizo Izigaba
Imikhiqizo efakiwe
Amathebulethi eLenopril Anika Amandla Ukulawula Umfutho Wegazi kanye Nempilo Yenhliziyo

Amathebulethi eLenopril Anika Amandla Ukulawula Umfutho Wegazi kanye Nempilo Yenhliziyo
I-Telmisartan I-antihypertensive Protecting renal engcono

I-Telmisartan I-antihypertensive Protecting renal engcono
I-Flumazenil I-GABAA Receptor Antagonist ekhethiwe kanye nezicelo zayo zokwelapha

I-Flumazenil I-GABAA Receptor Antagonist ekhethiwe kanye nezicelo zayo zokwelapha
I-Trametinib Kinase Inhibitor Targeting BRAF V600 Mutation-Positive Cancers

I-Trametinib Kinase Inhibitor Targeting BRAF V600 Mutation-Positive Cancers
I-Dabrafenib I-Targeted Therapy ye-BRAF-Mutated Cancers

I-Dabrafenib I-Targeted Therapy ye-BRAF-Mutated Cancers
I-Tirzepatide Dual GLP-1 kanye ne-GIP Receptor Agonist for Weight Management and Glycemic Control

I-Tirzepatide Dual GLP-1 kanye ne-GIP Receptor Agonist for Weight Management and Glycemic Control
I-Cisapride Gastric Stimulant for Indigestion and Digestive Disorders

I-Cisapride Gastric Stimulant for Indigestion and Digestive Disorders
I-YK-11 I-SARM Enamandla Yokwakhiwa Kwemisipha, Ukuzuza Amandla, kanye Ne-Myostatin Inhibition

I-YK-11 I-SARM Enamandla Yokwakhiwa Kwemisipha, Ukuzuza Amandla, kanye Ne-Myostatin Inhibition
I-Ostarine (MK-2866) I-SARM Eguquguqukayo Yokukhula Kwemisipha, Ukulahlekelwa Kwamafutha, Nokubuyiswa Komzimba

I-Ostarine (MK-2866) I-SARM Eguquguqukayo Yokukhula Kwemisipha, Ukulahlekelwa Kwamafutha, Nokubuyiswa Komzimba
I-MK-677 Inhlanganisela Eyingqayizivele Yokukhula Kwemisipha, Ukukhuthazela, Nokubuyiselwa

I-MK-677 Inhlanganisela Eyingqayizivele Yokukhula Kwemisipha, Ukukhuthazela, Nokubuyiselwa
0102030405
I-YK-11 I-SARM Enamandla Yokwakhiwa Kwemisipha, Ukuzuza Amandla, kanye Ne-Myostatin Inhibition
I-YK-11 I-SARM Enamandla Yokwakhiwa Kwemisipha, Ukuzuza Amandla, kanye Ne-Myostatin Inhibition
I-YK-11 I-SARM Enamandla Yokwakhiwa Kwemisipha, Ukuzuza Amandla, kanye Ne-Myostatin Inhibition
I-YK-11 I-SARM Enamandla Yokwakhiwa Kwemisipha, Ukuzuza Amandla, kanye Ne-Myostatin Inhibition

I-YK-11 I-SARM Enamandla Yokwakhiwa Kwemisipha, Ukuzuza Amandla, kanye Ne-Myostatin Inhibition

Intengo Yereferensi:USD 40-150/g

  • Igama Lomkhiqizo YK11
  • Inombolo ye-CAS. 431579-34-9
  • MF I-C25H34O6
  • MW 430.541
  • Ukuminyana 1.2±0.1 g/cm3
  • Iphuzu elibilayo 564.4±50.0 °C ku-760 mmHg
Xhumana nathi
imininingwane yomkhiqizo

Incazelo Eningiliziwe

I-YK-11 iyi-modulator ye-androgen receptor (SARM) ekhethiwe ethole ukuthandwa emphakathini wokwakha umzimba. Kuyaziwa ngekhono layo lokunamathisela ngokukhetha kuma-androgen receptors athile, ukuvimbela umsebenzi we-myostatin nokukhuthaza ukukhula kwemisipha. Lesi sihloko sihlola ukuthi i-YK-11 isebenza kanjani, izinzuzo zayo ekwakheni umzimba, ukusetshenziswa okunconyiwe, kanye nokusebenza kwayo ekwakhiweni kwemisipha (bulking) nokulahlekelwa kwamafutha (ukusika).

I. Ukuqonda i-YK-11:
A. YK-11 njenge-SARM ene-androgen receptor ebophayo
B. Ihlukile kuma-anabolic steroids, aqondise ama-receptors athile
C. Ukuvinjelwa kwephrotheni ye-myostatin ukukhuthaza ukukhula kwemisipha
D. Isakhiwo esifanayo sejometri kuma-anabolic steroids

II. Indlela Yesenzo:
A. Indima ye-Myostatin ekuvimbeleni ukukhula kwemisipha
B. Indima ye-Follistatin ekuzuzweni kwemisipha namandla
Ikhono le-C. YK-11 lokwehlisa amazinga e-myostatin nokwandisa i-follistatin
D. Ukungeniswa kwamangqamuzana emisipha ukuze kukhiqizwe i-follistatin eyengeziwe

1715511746462bxe

III. Izinzuzo ze-YK-11:

A. Isisindo somzimba esithuthukisiwe namandla azuzayo

B. Amathuba okudlula imikhawulo yokukhula kwemisipha yofuzo

C. Ukuthuthukiswa kokuqina kwamathambo nokukhula kwamangqamuzana amathambo

D. Ukufana ne-testosterone ekukhuthazeni ukukhula kwemisipha


IV. Ukusetshenziswa kwe-YK-11 Ekwakhiweni Komzimba:

A. Ifanele ukunqwabelana, ukusika, nomjikelezo wokubuyisela

B. Umthamo onconyiwe: 10-15 mg/day for mass building

C. Abasebenzisi bokuqala kufanele baqale ngama-SARM athambile

D. Ukungaguquguquki kokuqeqeshwa kanye nokudla okufanele kubalulekile


V. YK-11 Umjikelezo Nesilinganiso:

A. Ubude besikhathi esisebenzayo nesiphephile somjikelezo: 8 amaviki

B. Umthamo onconyiwe osuselwe kusisindo somzimba (10-15 mg/ngosuku)

C. Umthamo olondolozayo wabasebenzisi bokuqala noma ngesikhathi sokusika/ukubuyisela (5 mg/ngosuku)

D. PCT (Post Cycle Therapy) nge-Clomid (20 mg/day) amaviki angu-4


VI. I-YK-11 Yokwakha Imisipha (Ukugcwala Okuningi) Nokulahlekelwa Kwamafutha (Ukusika):

A. Ukuhlukahluka kwe-YK-11 kuzo zombili izinhloso

B. Isilinganiso esiphansi ngesikhathi sokulahlekelwa kwamafutha ukuze kugcinwe isisindo semisipha

C. Ukuhlola ukubekezelelana kanye nokukhuphuka kwethamo okungaba khona ekwakheni imisipha

D. Izinketho zesitaki nge-LGD 4033 ukuze uthole imiphumela ethuthukisiwe


Ngaphezu kwalokho, i-tadalafil isetshenziselwa ukuphatha i-pulmonary arterial hypertension(PAH) kokubili amadoda nabesifazane. Kulolu hlelo lokusebenza, kusiza ukuthuthukisa amandla okuzivocavoca futhi kubambezele ukuwohloka komtholampilo kwalesi sifo.

imikhiqizo1 (3)hq6imikhiqizo1 (4)mnpimikhiqizo1 (6)zef


I-YK-11 iyi-SARM enamandla enikeza izinzuzo ezibalulekile zokwakha imisipha, izinzuzo zamandla, kanye nokuvinjelwa kwe-myostatin. Ikhono layo lokukhomba ngokukhetha ama-androgen receptors kanye nokulawula amazinga e-myostatin kwenza kube inhlanganisela ebalulekile ekwakheni umzimba. Kungakhathaliseki ukuthi i-bulking noma ukusika, i-YK-11 ingafakwa emijikelezweni enedosi efanele kanye nobude besikhathi somjikelezo, ephelezelwa Ukwelashwa Komjikelezo Okufanele. Nakuba i-YK-11 isebenza kakhulu, kubalulekile ukubeka phambili ukuphepha futhi ulandele imihlahlandlela yokusetshenziswa enconyiwe ukuze wandise izinzuzo zayo.
Njengomphakeli ochwepheshe, singakwazi ukwenza ngokwezifiso i-capsule nemikhiqizo yoketshezi, ngokuya ngezidingo zakho zezithako.
Singakwazi ukwenza ngokwezifiso umthamo: 500mg/capsule, 550mg/capsule, 600mg/capsule.
Singakwazi ukwenza ngokwezifiso ukupakishwa: 60 caps / ibhodlela, 90 caps / ibhodlela, 120 caps / ibhodlela.
Singakwazi ukwenza ngokwezifiso amagobolondo we-capsule nemibala: amagobolondo e-capsule yezitshalo, amagobolondo we-gelatin capsule.

Ukucaciswa

1715510761484akv